Sam Altman is a prominent entrepreneur, investor, and the CEO of OpenAI. His investments in Neurotech companies such as Neuron23 highlight his interest in revolutionary technologies, including brain-computer interfaces and neural innovations. Altman's strategic backing has fueled advancements in Neurotech, aiming to unlock new frontiers in understanding the brain, cognitive enhancement, and potential therapeutic breakthroughs.